Drug Search Results

Galeterone

Alternative Names: galeterone, tok-001
Latest Update: 2023-10-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: AR Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Eledon Pharmaceuticals
Company Location: IRVINE CA 92612
Company CEO: David-Alexandre C. Gros
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Galeterone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Prostate Cancer

Phase 2: Adenocarcinoma|Prostate Cancer|Pancreatic Cancer

Phase 1: Healthy Volunteers|Prostate Cancer

Trial	Phase	Trial Status	Disease	Primary Completion Date
1911GCCC	P2	Recruiting	Adenocarcinoma\|Pancreatic Cancer	2025-12-31
ARMOR3-SV	P3	Completed	Prostate Cancer	2016-10-31
ARMOR2	P2	Terminated	Prostate Cancer	2016-09-01
ARMOR3-SV	P3	Terminated	Prostate Cancer	2016-07-01

Recent News Events

Date	Type	Title
10/01/2023	PubMed	Salinization Dramatically Enhance the Anti-Prostate Cancer Efficacies of AR/AR-V7 and Mnk1/2 Molecular Glue Degraders, Galeterone and VNPP433-3beta Which Outperform Docetaxel and Enzalutamide in CRPC CWR22Rv1 Xenograft Mouse Model.
09/12/2023	PubMed	AURKA inhibitor-induced PD-L1 upregulation impairs antitumor immune responses.
06/21/2023	PubMed	Can the Oral Bioavailability of the Discontinued Prostate Cancer Drug Galeterone Be Improved by Processing Method? KinetiSol Outperforms Spray Drying in a Head-to-head Comparison.
04/08/2019	News Article	Hoth Therapeutics, Inc. Announces the Addition of Dr. Lawrence A. Schachner, M.D. and Dr. Vincent C.O. Njar, Ph.D. to the Company's Scientific Advisory Board

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions